The European Directorate for Quality of Medicines (EDQM) and USFDA have inspected the Active Pharmaceutical Ingredients site from October 14 - 18, 2013. USFDA has issued their observations in a form 483. EDQM is yet to submit its final inspection report. After the resolution of the observations to the satisfaction of the regulators, the company will be able to resume supplies of its products to the EU and USA markets.
Shares of Smruthi Organics Ltd was last trading in BSE at Rs.66.15, up by Rs.3.15 or 5%. The stock hit an intraday high of Rs.66.15 and low of Rs.66.15.
The total traded quantity was 25 as compared to 2 week average of 210.